Verition Fund Management
DMIIU

Verition Fund Management’s Drugs Made In America Acquisition II Corp Unit DMIIU Stock Holding History

Verition Fund Management’s Portfolio DMIIU Stock Details DMIIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.54M Hold
250,000
– – 0.01% 981
2026
Q1 		$2.51M Hold
250,000
– – 0.02% 901
2025
Q4 		$2.5M Sell
250,000
-200,000
-44% -$2M 0.01% 1409
2025
Q3 		$4.48M Buy
+450,000
New +$4.49M 0.02% 1271

Other funds holding DMIIU

LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $3.04B AUM 26.78% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Verition Fund Management's DMIIU Position: Q2 2026 in Review

Verition Fund Management held its Drugs Made In America Acquisition II Corp Unit (DMIIU) position steady in Q2 2026 at 250,000 shares worth $2.54M. The position accounts for 0.01% of the portfolio, ranked #981.

Verition Fund Management first reported a position in DMIIU in Q3 2025 and has held it in 4 quarters since. The position peaked at $4.48M in Q3 2025. 11 funds tracked by Wall St. Rank hold DMIIU as of Q2 2026.

  • Verition Fund Management held 250,000 shares of Drugs Made In America Acquisition II Corp Unit worth $2.54M as of Q2 2026.
  • Verition Fund Management left its Drugs Made In America Acquisition II Corp Unit share count unchanged in Q2 2026.
  • Drugs Made In America Acquisition II Corp Unit made up 0.01% of Verition Fund Management's portfolio in Q2 2026, its #981 holding.
  • Verition Fund Management first reported a position in Drugs Made In America Acquisition II Corp Unit in Q3 2025 and has held it in 4 quarters since.
  • Verition Fund Management's Drugs Made In America Acquisition II Corp Unit position peaked at $4.48M in Q3 2025.
  • 11 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp Unit as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.